These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 33704664)
1. Regarding chronic graft-versus-host disease in children and adolescents with thalassemia after hematopoietic stem cell transplantation. Janowiak-Majeranowska A; Majeranowski A Int J Hematol; 2021 Jul; 114(1):147-148. PubMed ID: 33704664 [No Abstract] [Full Text] [Related]
2. Chronic graft-versus-host disease in children and adolescents with thalassemia after hematopoietic stem cell transplantation. Lertkovit O; Anurathapan U; Hongeng S; Thokanit NS; Pakakasama S Int J Hematol; 2021 Apr; 113(4):556-565. PubMed ID: 33385291 [TBL] [Abstract][Full Text] [Related]
3. Hematopoietic Stem Cell Transplantation in Thalassemia. Strocchio L; Locatelli F Hematol Oncol Clin North Am; 2018 Apr; 32(2):317-328. PubMed ID: 29458734 [TBL] [Abstract][Full Text] [Related]
4. Unrelated Donor Transplantation in Children with Thalassemia using Reduced-Intensity Conditioning: The URTH Trial. Shenoy S; Walters MC; Ngwube A; Soni S; Jacobsohn D; Chaudhury S; Grimley M; Chan K; Haight A; Kasow KA; Parikh S; Andreansky M; Connelly J; Delgado D; Godder K; Hale G; Nieder M; Pulsipher MA; Trachtenberg F; Neufeld E; Kwiatkowski JL; Thompson AA Biol Blood Marrow Transplant; 2018 Jun; 24(6):1216-1222. PubMed ID: 29374585 [TBL] [Abstract][Full Text] [Related]
8. Acute and chronic Graft-versus-host disease after hematopoietic stem cell transplantation. Funke VA; Moreira MC; Vigorito AC Rev Assoc Med Bras (1992); 2016 Oct; 62 Suppl 1():44-50. PubMed ID: 27982319 [TBL] [Abstract][Full Text] [Related]
9. Transplant Outcomes in Beta-Thalassemia Major Patients Receiving Combined Granulocyte Colony-Stimulating Factor-Primed Bone Marrow and Cord Blood Graft Compared to Granulocyte Colony-Stimulating Factor-Primed Bone Marrow Alone. Wen J; Haque Q; Pei F; Chen L; Ruan Y; Liu X; He Y; Feng X; Li C; Wu X Acta Haematol; 2018; 140(1):20-29. PubMed ID: 30071526 [TBL] [Abstract][Full Text] [Related]
10. Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Socié G; Loiseau P; Tamouza R; Janin A; Busson M; Gluckman E; Charron D Transplantation; 2001 Aug; 72(4):699-706. PubMed ID: 11544434 [TBL] [Abstract][Full Text] [Related]
11. Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell Transplantation. Shenoy S; Angelucci E; Arnold SD; Baker KS; Bhatia M; Bresters D; Dietz AC; De La Fuente J; Duncan C; Gaziev J; King AA; Pulsipher MA; Smith AR; Walters MC Biol Blood Marrow Transplant; 2017 Apr; 23(4):552-561. PubMed ID: 28065838 [TBL] [Abstract][Full Text] [Related]
12. High risk of chronic graft-versus-host disease in unmanipulated allogeneic peripheral blood stem cell transplantation. Kalayoğlu-Beşişik S; Budak-Alpdoğan T; Nuri Yenerel M; Sargin D; Tangün Y Blood; 1998 Oct; 92(8):2973-5. PubMed ID: 9763587 [No Abstract] [Full Text] [Related]
13. Matched Family versus Alternative Donor Hematopoietic Stem Cell Transplantation for Patients with Thalassemia Major: Experience from a Tertiary Referral Center in South India. Swaminathan VV; Uppuluri R; Patel S; Ravichandran N; Ramanan KM; Vaidhyanathan L; Ramakrishnan B; Jayakumar I; Raj R Biol Blood Marrow Transplant; 2020 Jul; 26(7):1326-1331. PubMed ID: 32200123 [TBL] [Abstract][Full Text] [Related]
14. Cutaneous graft-versus-host disease after hematopoietic stem cell transplant - a review. Villarreal CD; Alanis JC; Pérez JC; Candiani JO An Bras Dermatol; 2016; 91(3):336-43. PubMed ID: 27438202 [TBL] [Abstract][Full Text] [Related]
15. Photopheresis long after the initiation of chronic graft versus host in a child. Uygun V; Daloglu H; Karasu G; Yeşilipek A Transfus Apher Sci; 2014 Oct; 51(2):172-4. PubMed ID: 25217990 [TBL] [Abstract][Full Text] [Related]
16. Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies Using a Tailored Busulfan-Based Conditioning Regimen: Single-Center Experience. Zaidman I; Rowe JM; Khalil A; Ben-Arush M; Elhasid R Biol Blood Marrow Transplant; 2016 Jun; 22(6):1043-1048. PubMed ID: 27016193 [TBL] [Abstract][Full Text] [Related]
17. [Haploidentical hematopoietic stem cell transplantation for beta-thalassemia major in children]. Hao WG; Sun X; Liu S; Zhao Z; Chen ZX Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jul; 11(7):546-8. PubMed ID: 19650987 [TBL] [Abstract][Full Text] [Related]
18. Graft-versus-host Disease Prophylaxis With Abatacept Reduces Severe Acute Graft-versus-host Disease in Allogeneic Hematopoietic Stem Cell Transplant for Beta-thalassemia Major With Busulfan, Fludarabine, and Thiotepa. Khandelwal P; Yeh RF; Yu L; Lane A; Dandoy CE; El-Bietar J; Davies SM; Grimley MS Transplantation; 2021 Apr; 105(4):891-896. PubMed ID: 32467478 [TBL] [Abstract][Full Text] [Related]
19. Is there an increased risk of graft-versus-host disease after allogeneic peripheral blood stem cell transplantation? Koc H; Gürman G; Arslan O; Ozcan M; Akan H; Ilhan O; Konuk N; Beksaç M; Uysal A Blood; 1996 Sep; 88(6):2362-4. PubMed ID: 8822963 [No Abstract] [Full Text] [Related]
20. [Clinical manifestation and related-risk factors analysis of chronic graft-versus-host disease]. Weng JY; Du X; Lu ZS Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):168-70. PubMed ID: 23611230 [No Abstract] [Full Text] [Related] [Next] [New Search]